Monday’s $191.5 billion combination of Pfizer and Allergan pushes worldwide announced M&A to $4.2 trillion, surpassing the all-time annual record for global deal making set in 2007.
Activist investor Carl Icahn turned up the pressure on American International Group to separate into three public companies.
Accountants, estate agents and art dealers who breached money-laundering rules were fined an average of just £1,134 last year, according to a report that says the UK’s anti-money laundering controls are not fit for purpose.
It's getting tougher out there.
Credit Suisse is reviewing its pay structure for 12 top executives after scrapping profitability targets under a strategy introduced by new CEO Tidjane Thiam.
George Osborne could be forced to borrow billions of pounds more than forecast by 2020 if he sticks with spending cuts that will hit economic growth, according to a report by City University.
Pfizer announced Monday it will buy Allergan for $363.63 a share, or about $160 billion.
Aberdeen Asset Management is likely to make four or five smaller acquisitions in 2016, its CEO said, once a downturn in its key Asian and emerging markets ends.
Brokers at ICAP ran an elaborate, four-year con on Tom Hayes, tricking the former UBS trader into believing they were helping him rig Libor, a former employee accused of conspiring with Hayes told London jurors.
Royal Bank of Scotland CEO Ross McEwan left it open as to whether he’ll take his first bonus since joining the bank in 2013
U.S. banks are in much better shape than they were years ago, EY Global Chairman and CEO Mark Weinberger said Wednesday.
It is a remarkable thing to say about Goldman Sachs but, to judge by vice chairman Michael Sherwood’s shrunken and apologetic demeanour in front of MPs, he knows it himself: the investment bank was a naive fool in the BHS debacle.
The vote to leave the EU has exposed divisions in society that mean reform of executive pay at big companies is urgently required, according to one of the UK’s top fund managers.